Preclinical Efficacy of Tasquinimod in Myelodysplastic Neoplasms: Restoring Erythropoiesis and Mitigating Bone Loss
Manja Wobus, Heike Weidner, Rebekka Wehner, Anna-Lena Baumann, Kristin Möbus, Ekaterina Balaian, Marie Törngren, Erik Vahtola, Helena Eriksson, Susann Winter, Uwe Platzbecker, Triantafyllos Chavakis, Lorenz Christian Hofbauer, Martina Rauner, Martin Bornhäuser, Katja Sockel
This study evaluates tasquinimod's efficacy in MDS by showing it reduces inflammation, improves erythropoiesis, and enhances bone health in a mouse model.
HemaSphere · Apr 1, 2026Peer-reviewedCell Biology